The PE ratio for Elevance Health stock stands at 18.37 as of Jul 26, 2024. This is calculated based on the current EPS of $28.72 and the stock price of $527.5 per share. The current price-to-earnings ratio is nearly the same as the last four quarters average.
Over the last ten years, the average PE ratio of Elevance Health has been 16.38. The current 18.37 PE ratio is 12% above the historical average. Over the past ten years, ELV's PE ratio was at its highest in the Jun 2021 quarter at 22.09, with a price of $381.8 and an EPS of $17.28. The Jun 2020 quarter recorded the bottom point at 11.24, with a price of $262.98 and an EPS of $23.39.
Maximum annual increase: 21.84% in 2014
Maximum annual decrease: -11.17% in 2019
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 18.58 | -11.06% |
| 2022 | 20.89 | 13.84% |
| 2021 | 18.35 | 4.2% |
| 2020 | 17.61 | 9.65% |
| 2019 | 16.06 | -11.17% |
| 2018 | 18.08 | 18.09% |
| 2017 | 15.31 | 0% |
| 2016 | 15.31 | 6.84% |
| 2015 | 14.33 | 6.15% |
| 2014 | 13.5 | 21.84% |
The current PE ratio of ELV is above the 3, 5 and 10-year historical averages.
| Stock name | PE ratio | Market cap |
|---|---|---|
| ELV Elevance Health Inc | 18.37 | $122.32B |
| LIFW MSP Recovery Inc | N/A | $57.5M |
| NEUE NeueHealth Inc. | N/A | $49.59M |
| OSCR Oscar Health Inc | N/A | $3.75B |
The price to earnings ratio for ELV stock as of Jul 26, 2024, stands at 18.37.
The 3-year average PE ratio for ELV stock is 18.35.
The 5-year average PE ratio for ELV stock is 17.31.
The highest quarterly PE ratio in the last ten years has been 22.09 and it was in the Jun 2021 quarter.
The current price to earnings ratio of ELV is 12% higher than the 10-year historical average.
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Jul 26, 2024), Elevance Health's stock price is $527.5. The earnings per share for the trailing twelve months (TTM) ending Jun 2024 is $28.72. Therefore, Elevance Health's P/E ratio for today is 18.37. PE RATIO(18.37) = STOCK PRICE($527.5) / TTM EPS($28.72)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.